4//SEC Filing
Kruse Bo 4
Accession 0001415889-24-001644
CIK 0001722964other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:48 PM ET
Size
14.3 KB
Accession
0001415889-24-001644
Insider Transaction Report
Form 4
Kruse Bo
DirectorEVP, CFO, Secy & Treas.
Transactions
- Award
Common Stock
2024-01-18+18,100→ 210,877 total - Award
Employee Stock Option (right to buy)
2024-01-18+108,900→ 108,900 totalExercise: $9.83Exp: 2034-01-18→ Common Stock (108,900 underlying)
Footnotes (3)
- [F1]Represents 18,100 restricted stock units ("RSUs") granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of January 18, 2025, January 18, 2026 and January 18, 2027 subject to the continuing employment of the Reporting Person on each vesting date.
- [F2]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F3]The stock options shall vest and become exercisable as to 25% of the shares subject to the option on January 18, 2025, and thereafter vest and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001752940
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 5:48 PM ET
- Size
- 14.3 KB